RXRX · NASDAQ
Recursion Pharmaceuticals (RXRX) Stock Price & Fundamentals
Recursion Pharmaceuticals (RXRX) closed at $806.57 on Oct 9, 2026, up 0.16% from the previous close of $805.27.
Share price, past year
1Y +22.58%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $806.57 |
| Sep 30, 2026 | $818.65 |
| Aug 31, 2026 | $771.62 |
| Jul 31, 2026 | $776.05 |
| Jun 30, 2026 | $760.25 |
| May 29, 2026 | $757.42 |
| Apr 30, 2026 | $782.09 |
| Mar 31, 2026 | $759.78 |
| Feb 27, 2026 | $794.07 |
| Jan 30, 2026 | $780.06 |
| Dec 31, 2025 | $730.42 |
| Nov 28, 2025 | $664.50 |
| Oct 31, 2025 | $688.23 |
Key statistics
- Market cap
- $430.81B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.00
- Revenue (TTM)
- $54.86M
- Net income (TTM)
- −$518.88M
- Shares outstanding
- 534.1M
- Dividend yield
- —
- 52-week range
- $655.75 – $831.91
Recursion Pharmaceuticals's market cap is $430.81B, based on a share price of $806.57 and 534.1M shares outstanding as of Jun 30, 2026.
Financials
Recursion Pharmaceuticals reported revenue of $74.68M for fiscal 2025, up 26.92% from fiscal 2024.
Recursion Pharmaceuticals reported a net loss of $644.76M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $74.68M | +26.9% | −$644.76M | −863.4% | −$1.44 | −$378.28M |
| FY2024ended Dec 31, 2024 | $58.84M | +32.0% | −$463.66M | −788.0% | −$1.69 | −$372.87M |
| FY2023ended Dec 31, 2023 | $44.58M | +11.9% | −$328.07M | −736.0% | −$1.58 | −$299.74M |
| FY2022ended Dec 31, 2022 | $39.84M | +291.5% | −$239.48M | −601.1% | −$1.36 | −$120.58M |
| FY2021ended Dec 31, 2021 | $10.18M | +156.9% | −$186.48M | −1,832.2% | −$1.49 | −$198.41M |
| FY2020ended Dec 31, 2020 | $3.96M | +70.9% | −$87.01M | −2,196.0% | −$3.99 | −$51.23M |
| FY2019ended Dec 31, 2019 | $2.32M | — | −$61.88M | −2,668.4% | −$2.87 | −$60.95M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $7.67M | −$131.01M | −$0.25 |
| Q1 FY2026ended Mar 31, 2026 | $6.47M | −$117.50M | −$0.22 |
| Q4 FY2025ended Dec 31, 2025 | $35.54M | −$108.12M | −$0.17 |
| Q3 FY2025ended Sep 30, 2025 | $5.18M | −$162.25M | −$0.36 |
| Q2 FY2025ended Jun 30, 2025 | $19.22M | −$171.90M | −$0.41 |
| Q1 FY2025ended Mar 31, 2025 | $14.75M | −$202.49M | −$0.50 |
| Q4 FY2024ended Dec 31, 2024 | $4.55M | −$178.91M | −$0.56 |
| Q3 FY2024ended Sep 30, 2024 | $26.08M | −$95.84M | −$0.34 |
Company profile
- Name
- Recursion Pharmaceuticals, Inc.
- Ticker
- RXRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 41s Rio Grande Street, Salt Lake City, UT 84101
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001601830
Recent SEC filings
- Sep 21, 2026
- Aug 5, 2026
- Aug 5, 2026
- Jun 18, 2026
- May 6, 2026
- May 6, 2026
- Apr 30, 2026
- Mar 25, 2026
Frequently asked questions
What is Recursion Pharmaceuticals's stock price?
Recursion Pharmaceuticals (RXRX) closed at $806.57 on Oct 9, 2026, up 0.16% from the previous close of $805.27.
What is Recursion Pharmaceuticals's market cap?
Recursion Pharmaceuticals's market cap is $430.81B, based on a share price of $806.57 and 534.1M shares outstanding as of Jun 30, 2026.
How much revenue does Recursion Pharmaceuticals make?
Recursion Pharmaceuticals reported revenue of $74.68M for fiscal 2025, up 26.92% from fiscal 2024.
Does Recursion Pharmaceuticals pay a dividend?
Recursion Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Recursion Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures